Liraglutide Fixes Learning Limit Tied to Insulin Resistance

A single injection of the GLP-1 receptor agonist liraglutide led to short-term normalization of associative learning in people with obesity and insulin resistance, a finding that suggests dopamine-driven learning processes are modified by metabolic signaling and that this effect “may contribute to the weight-reducing effects of liraglutide in obesity,” say the authors of a recent report in Nature Metabolism. “We […]
» Read more